Of the 34 genes, NOS3, ADK, ACE, AGT and PIK3CB were identified as being druggable targets37 (Supplementary Table 5), however the impact of therapeutics on the risk of cardiovascular disease associated with SARS-CoV-2 remains unknown. The gene discussed is ADK; the disease is cardiovascular disorder.